Guggenheim Capital LLC Invitae Corp Transaction History

Guggenheim Capital LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.42 - $0.72 $28,359 - $48,616	-67,523 Reduced 15.49%	368,294 $232,000
Q3 2023 Nov 14, 2023	BUY	$0.6 - $1.53 $2,607 - $6,649	4,346 Added 1.01%	435,817 $261,000
Q2 2023 Aug 11, 2023	BUY	$1.05 - $1.63 $117,540 - $182,467	111,943 Added 35.03%	431,471 $487,000
Q1 2023 May 10, 2023	BUY	$1.2 - $2.73 $23,239 - $52,869	19,366 Added 6.45%	319,528 $431,000
Q4 2022 Feb 14, 2023	SELL	$1.71 - $3.61 $49,126 - $103,711	-28,729 Reduced 8.74%	300,162 $558,000

Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $14,346 - $65,165	-7,551 Reduced 2.24%	328,891 $809,000
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $344,012 - $1.46 Million	-161,508 Reduced 32.43%	336,442 $821,000
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $191,671 - $475,822	30,521 Added 6.53%	497,950 $3.97 Million
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $1.67 Million - $3.26 Million	113,780 Added 32.17%	467,429 $7.14 Million
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $6.7 Million - $9.26 Million	275,559 Added 352.87%	353,649 $10.1 Million
Q2 2021 Aug 13, 2021	BUY	$26.09 - $40.4 $166,949 - $258,519	6,399 Added 8.93%	78,090 $2.63 Million
Q1 2021 May 13, 2021	SELL	$33.06 - $56.93 $7,669 - $13,207	-232 Reduced 0.32%	71,691 $2.74 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $2.81 Million - $4.13 Million	71,923 New	71,923 $3.01 Million
Q2 2018 Aug 14, 2018	SELL	$4.87 - $8.42 $73,011 - $126,232	-14,992 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.69 - $10.05 $70,312 - $150,669	14,992 New	14,992 $70,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.